BEST4 Screening Trial
Large-scale randomized controlled trial for population screening of Barrett's Esophagus
Clinical TrialActive
Key Facts
Indication
Large-scale randomized controlled trial for population screening of Barrett's Esophagus
Phase
Clinical Trial
Status
Active
Company
About Cyted Health
Cyted Health is a commercial-stage diagnostics company focused on revolutionizing the early detection of gastrointestinal diseases, particularly esophageal cancer and its precursor, Barrett's Esophagus. Its core technology is the EndoSign® capsule sponge, a minimally invasive device for cell collection, which is integrated with advanced molecular diagnostics. The company has achieved significant milestones including FDA 510(k) clearance, initiation of a major UK screening trial (BEST4), and a $44 million Series B financing round to accelerate US expansion.
View full company profile